Arrowhead Pharmaceuticals, Inc. (ARWR) CEO Christopher Anzalone on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 02/06/20
Sarepta Therapeutics, Inc. And Arrowhead Pharmaceuticals Now Top-Ranked Biotech Stock BuysSeeking Alpha • 02/01/20
Arrowhead Pharmaceuticals, Inc.: A Better Odds-On Capital-Gain Alternative To AlkermesSeeking Alpha • 01/28/20
This Highly Rated Biotech Company Just Tumbled 13% On A Public OfferingInvestors Business Daily • 12/02/19
This Biotech With 456% Growth In 2019 Just Gained A Price-Target BoostInvestors Business Daily • 11/29/19
Arrowhead Pharmaceuticals, Inc. (ARWR) CEO Christopher Anzalone on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/26/19